Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold since inception. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021
John Philip Jones, insider at Alimera Sciences
John Philip Jones Insider Alerts

Get notified the next time John Philip Jones buys or sells Alimera Sciences stock. Enter your email address below to get our daily insider buying and selling report.

John Philip Jones Insider Information

Mr. Jones has been our Chief Financial Officer since January 2, 2019. From August 2016, he served as the Company’s VP Finance and Assistant Corporate Secretary and joined Alimera in June of 2015 as Corporate Controller. Prior to Alimera, Mr. Jones held various senior financial leadership roles in Theragenics Corporation, a medical product manufacturing company, Superior Essex, a communications cable company, and Arjo Wiggins Medical, the medical materials division of Arjo Wiggins Appleton. Mr. Jones began his financial career in 1986 as an accountant for a large regional CPA firm in Atlanta, Georgia. Mr. Jones is a Certified Public Accountant in the state of Georgia and is a graduate of Auburn University with a B.S.B.A. degree with an emphasis in accounting.

How do I contact John Philip Jones?

The corporate mailing address for Mr. Jones and other Alimera Sciences executives is 6120 WINDWARD PARKWAY STE 290, ALPHARETTA GA, 30005. Alimera Sciences can also be reached via phone at (678) 990-5740 and via email at [email protected]

Has John Philip Jones been buying or selling shares of Alimera Sciences?

Within the last three months, John Philip Jones has bought $20,400.00 in Alimera Sciences stock. Most recently, on Wednesday, November 3rd, John Philip Jones bought 5,000 shares of Alimera Sciences stock. The stock was acquired at an average cost of $4.08 per share, with a total value of $20,400.00.

Who are Alimera Sciences' active insiders?

Alimera Sciences' insider roster includes Philip Ashman (COO), Richard Eiswirth, Jr. (CEO), John Jones (CFO), and James Largent (Director).

Are insiders buying or selling shares of Alimera Sciences?

During the last year, Alimera Sciences insiders bought shares 4 times. They purchased a total of 44,405 shares worth more than $195,822.25. During the last year, insiders at the biopharmaceutical company sold shares 1 times. They sold a total of 45 shares worth more than $432.90. The most recent insider tranaction occured on November, 5th when CEO Richard S Eiswirth Jr bought 1,400 shares worth more than $7,700.00. Insiders at Alimera Sciences own 13.5 % of the company.

Information on this page was last updated on 11/5/2021.

John Philip Jones Insider Trading History at Alimera Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/3/2021Buy5,000$4.08$20,400.00View SEC Filing Icon  
See Full Table

John Philip Jones Buying and Selling Activity at Alimera Sciences

This chart shows John Philip Jones's buying and selling at Alimera Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alimera Sciences Company Overview

Alimera Sciences logo
Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the following geographical segments: U.S. and International. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.
Read More

Today's Range

Now: $5.35
Low: $5.28
High: $5.87

50 Day Range

MA: $4.86
Low: $3.95
High: $6.59

2 Week Range

Now: $5.35
Low: $3.94
High: $12.25


19,966 shs

Average Volume

138,739 shs

Market Capitalization

$37.13 million

P/E Ratio


Dividend Yield



Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity